Clinical Trial: GDC-0449 in Treating Patients With High-Risk First Remission or Relapsed Multiple Myeloma Who Received an Autologous Stem Cell Transplant
Sponsor and Collaborators
Sidney Kimmel Comprehensive Cancer Center
National Cancer Institute (NCI)
Carol A. Huff, MD Sidney Kimmel Comprehensive Cancer Center
Next post in Multiple Myeloma Clinical Trials
Log in to continue reading this article.
Don’t miss out on today’s top content on Oncology Nurse Advisor. Register for free and gain unlimited access to:
- Clinical Updates
- Evidence-Based Guidance
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
Want to read more?
Please login or register first to view this content.